The Swiss HIV Cohort Study: Rationale, organization and selected baseline characteristics

Bruno Ledergerber1, von Overbeck J2, Matthias Egger3, Ruedi Lüthy4
1Department of Medicine, University Hospital, Zürich
2Medical Policlinic, University Hospital Berne, Berne, Deutschland
3Department of Social and Preventive Medicine, University of Berne, Berne, Deutschland
4Division of Infectious Diseases, dept. of medicine, University Hospital Zurich, Zurich, Switzerland

Tóm tắt

Từ khóa


Tài liệu tham khảo

Grob PJ. The HIV epidemic in Switzerland (in German and French). Bull BAG 1993;40:712?725.

Engel RR, Samuel MC, Rieder HL, Billo N, Somaini B. Completeness of AIDS reporting in Switzerland: a study based on deaths between December 1987 and June 1990. AIDS 1992;6:1385?1389.

von Overbeck J, Egger M, Smith GD, Ledergerber B. Survival in HIV infection: do sex and category of transmission matter? AIDS 1994; 8:1307?1313.

Frei A, Hill S. Das Schweizerische Gesundheitswesen: Zahlenspiegel, Anbieter von Gesundheitsgütern, Preisbildung, Organisationsstrukturen. Basel: Verlag Krebs AG; 1992:71.

Hirschel B, Lazzarin A, Chopard P et al. A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med 1991;324: 1079?1083.

Heald A, Flepp M, Chave JP et al. Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. Ann Interna Med 1991;115:760?763.

Böttger EC, Teske A, Krischner P et al. Disseminated ?Mycobacterium genavense? infection in patients with AIDS. Lancet 1992;340: 76?80.

Egger M, Wentworth D, von Overbeck J, Sherer R, Ledergerber B, Saravolatz L. Mortality in HIV infection in Switzerland and the United States. Tenth International Conference on AIDS, Yokohama 1994, PC 215.